Context: Pediatric nephrolithiasis is a noticeable cause of morbidity among children. Although, nephrolithiasis is a common disease in adults, its incidence has had a rising trend in children.
Context
Over the past decades, the prevalence of pediatric nephrolithiasis has increased by 70% in adults and has become the third top urinary tract disease, and the gender gap between males and females is narrowing in many countries, as about 10% and 5% of males and females, respectively, complain of this condition during their life (1) (2) (3) . Sas et al. (4) reported in their study that during the last couple of decades, the incidence of pediatric nephrolithiasis has increased by approximately 6 to 10% annually and has actually reached 50 per 100000 in adolescents.
This situation may cause some complications and has subsequent health care and medical costs. Pearle et al. (5) estimated that more than two billion dollars is incurred annually for nephrolithiasis in the United States. This condition causes further chronic conditions requiring health care services in pediatric medicine. Moreover, recent studies revealed that this disorder has a genderrelated distribution in this context by more inclination toward nephrolithiasis. In addition, race and geographic location may play a role in nephrolithiasis development. African countries have low prevalence and the Middle East, Pakistan and India have higher incidence of urolithiasis (6, were excluded. Moreover, the bibliography of relevant review articles recognized in our search was read and appropriate articles were selected. Consequently, the authors independently reviewed the abstracts and the papers, which matched the inclusion criteria and selected more recent publications. The flow diagram of the study selection process is shown in Figure 1 . Reviewed articles are summarized in Table 1 .
Results
From the total of 1050 studies identified through database searching, 71 articles were selected for the review. Among 71 reviewed articles, 11 were cross-sectional, 23 retrospective cohort, 11 prospective studies, 20 review articles, three lab studies, and three were clinical trials. The qualitative results derived from the reviewed articles related to incidence and trend, risk factors and causes of nephrolithiasis, clinical presentation, evaluation of the patients including history taking and physical examination, urinalysis and other laboratory evaluations, imaging studies, therapeutic approaches such as acute management, surgical management, prevention of recurrence are summarized in Table 1 , and discussed here.
Discussion

Incidence and Trend
The real incidence of nephrolithiasis in children remains non-conclusive. This fact is relatively secondary to multiple etiological factors and nonspecific clinical presentations. Multiple studies over the past decade have documented an increased incidence of nephrolithiasis in different countries (8) . In the United States, the result of the national health and nutrition examination survey (NHANES), as a cross-sectional survey presented an increasing estimation of nephrolithiasis in adults of this country. Furthermore, recent studies revealed that the incidence of hospital admissions increased from 1 in 7600 to 1 in 685 admissions from 1999 to 2007 among children. The annual increase was 10.6% on average (9). These epidemiologic changes could be due to life style modifications, particularly in eastern countries, and increased diagnosis of nephrolithiasis by using ultrasonography evaluation in children with specific or nonspecific symptoms. Besides, adult urologists are now referring more patients to pediatric centers. Yasui et al. (10) from Japan displayed an incidence of 12.4/100000 to 17.7/100000 in female and male children aged 10 -19 years old, respectively. Additionally, Edvardsson et al. (11) in Iceland reported an incidence of 5.6/100000 in patients younger than 18 years old. Furthermore, Routh et al. (12) in their study, by using national health information system database, declared an elevated incidence of nephrolithiasis in children. In an epidemiologic project in Minnesota from 1998 to 2008, the overall incidence of nephrolithiasis in adolescents was increased from 7 to 14 per 100000 patients aged 12 to 17 years old (13) . Tasian et al. (14) in a large population study indicated that between 1997 and 2012, the rate of nephrolithiasis increases annually by one percent. On the other hand, there has been a change regarding the gender of patients. Previous reports demonstrated that nephrolithiasis was usually more common in boys than in girls, but recent studies have shown a noticeable rising incidence of nephrolithiasis in girls and some studies even substantiated that nephrolithiasis are more common among girls (4, 9, 10, 12, 15, 16) . Usually girls in the second decade are more prone to hospital administration for kidney stone (12) . The possible relationship between nephrolithiasis, obesity, and metabolic syndrome was demonstrated in previous reports but it is not conclusive (16, 17) . As mentioned before, geographic location may affect nephrolithiasis development. Former studies revealed that nephrolithiasis is more common among non-Hispanic white individuals as compared with non-Hispanic black individuals in adults and pediatric populations (18) (19) (20) . In addition, age of children may have a role in this setting as in some studies, it was demonstrated that the incidence of nephrolithiasis has increased from 0.6 per 100000 in children aged less than three years old to 34.9 per 100000 among adolescents aged less than 18. They indicated that the risk of nephrolithiasis in age group of 14 to 18 years is 10 times greater. The hospitalization rate also follows the same pattern (9, 12, 21, 22) . In a Tasian study, the greatest change belonged to 15 to 19 year olds, and the incidence of nephrolithiasis increased by 26% per five years. The incidence increased by 15% per five years among females in general (14) .
Risk Factors and Causes of Nephrolithiasis
In general, nephrolithiasis in many cases is associated with a metabolic abnormality including hypercalciuria, hyperoxaluria, hypocitraturia, cystinuria, and hyperuricosuria, in which hypercalciuria or hypocitraturia are more frequent. However, we need to pay attention to some disorders such as cystic fibrosis (CF), spina bifida or inflammatory bowel disease, which may prone the patient to risk of stone recurrence or raise the possibility of stone formation such as oxalosis or Primary Hyperoxaluria (PH). This disorder has two types PH-1 and PH-2 (7, (23) (24) (25) . Tubular disorders such as cystinuria increased the risk of stone formation, which accounted for 3% of renal stones (26) . Some systemic diseases such as CF and inflammatory bowel diseases (IBD) may be associated with nephrolithiasis. These diseases usually affect the intestine and induce fat mal-absorption. Consequently, development of steatorrhea leads to chelating of calcium and absorption of oxalate from intestine and as a result leads to the development of calcium oxalate stones. Furthermore, renal tubular acidosis may be considered as an etiology of calcium phosphate stones. Struvite stones also in the setting of spinal cord injuries or neurogenic bladders might be considered. In patients with seizures, ketogenic diet and anti-seizer medications result in acidosis, hypercalciuria that need more attention (27) (28) (29) .
On the other hand, in recent studies, low fluid consumption, particularly water, has been considered as an etiological factor in kidney stone (20, 30, 31) . In fact, super saturation of ions in urine such as calcium and oxalate directly depend on the volume of urine, hence an appropriate hydration could protect the stone formation. Furthermore, it has been demonstrated that high intake of salt (sodium) increases the excretion of urinary calcium and stone formation (32, 33) . Although calcium in appropriate amounts may prevent oxalate absorption from the intestine, low intake of dietary calcium contributes to nephrolithiasis in adolescents (13) . Therefore, an appropriate dietary calcium intake is advised.
We need to reemphasize that pediatric nephrolithiasis has a high risk of recurrence, and reaches 40% in different studies. It is particularly related to metabolic or genetic predisposing factors. The risk of recurrence is more common in patients aged less than ten years, for whom a metabolic disorder is common (34, 35) . Among them, hypercalciuria, hyperuricosuria and cystinuria make 34 to 50%, 20% and 20% of metabolic abnormalities, respectively in pediatric nephrolithiasis (36) (37) (38) . In the recurrence of nephrolithiasis, we need to evaluate the patients for inherited disorder such as PH, cystinuria, Dent disease and familial hypomagnesemia (20, 39) . Moreover, mutations of CYP24A1, encoding the enzyme that influences conversion of active forms of vitamin D to inactive metabolites, induce idiopathic infantile hypercalcemia (40) . Moreover, mutation of SLC34A3 gene encoding sodium (Na+)-dependent phosphate cotransporter 2c (NPT2c) causes hereditary hypophosphatemic rickets with hypercalciuria that consequently may increase the risk of nephrolithiasis (41). There are not enough studies regarding obesity and pediatric nephrolithiasis. Obesity probably leads to a decreased urinary pH and increases the risk of uric acid stone. In a study in Turkey on 96 patients, the author concluded that overweight children with alteration of urine compositions, such as higher oxalate and uric acid and lower urine volume, are at the risk of forming of stone (42). Kieran et al. (43) also revealed that 41% of their patients were overweight or obese. Kurtz et al. (44) , in a populationbased study on 2871 patients aged 2 months to 18 years revealed that 420 (14.6%) were overweight and 440 (15.3%) were obese. They concluded that increased BMI in children was associated with increased overall complications. Generally, there is no consensus about obesity as a risk factor for nephrolithiasis and this association remains under question (15, 45) .
In Iran there are limited reports regarding the etiology of nephrolithiasis, but to the best of our knowledge, the pattern of nephrolithiasis and its related factors follow other reports. However, we need to focus on the fact that the Middle East region, including Iran, is a warm region with a rapidly changing life style to western nations. In this setting, Safaei Asl et al. (46) in their report on 78 patients indicated that 52.6% had a metabolic risk factor including normocalcemic hypercalciuria (21.7%), hyperuricosuria (11.5%), cystinuria (3.8%), and hyperoxaluria (5.1%). In addition, Mohammadjafari in a 10-year prospective study on 217 children, two months to 16 years old revealed that 35.1%, 10% and 4.1% of patients had metabolic, infective and obstructive problems, respectively. In this study, 110 children had no recognized etiology; furthermore hypercalciuria hyperoxaluria and hypocitraturia were seen in 25.5%, 18.4% and 18.1% of patients (47), respectively. In addition, Sadeghi et al. (48) in a study in the south east of Iran on 100 patients reported that hypercalciuria and hypocitraturia were seen in 56% and 64% of patients, respectively, followed by anatomic malformation (32%) and Urinary Tract Infections (UTI) (9%). Alemzadeh-Ansari et al. (49) also in a study on 152 infants from southwest of Iran revealed that the most common metabolic risk factors were hypercalciuria (79.6%) and hypocitraturia (40.9%). In this study hyperoxaluria and hypomagnesuria were found in about 28% of patients.
Clinical Presentation
The presentations of nephrolithiasis in children are variable. The classic adult presentation with flank pain radiated to the groin is not common and almost agedependent (33, 44, 50) . Although, adolescents usually present colicky pain similarity to adults, younger children have nonspecific symptoms including abdominal pain, nausea and vomiting or irritability. Hematuria, microscopic or macroscopic can occur in up to 90% of cases. In addition, urinary infection (UTI) in children less than five years old could be the main presentation (36) . Nonspecific and localized pain is typical of infants and young children with nephrolithiasis. Hematuria and uncharacteristic abdominal pain are common in only 10% to 14% of all pediatric cases (33, 37, 51) . However, nephrolithiasis is discovered incidentally, during imaging evaluation for other reasons, and remains asymptomatic for a long time (24, 33) . In our region, the symptoms generally follow the same pattern. Sadeghi et al. reported that the most common clinical presentations were irritability (62%), flank pain (33%) and gross hematuria (4%), while Sepahi et al. (48, 51) reported that of one hundred patients, 54% presented urinary tract infection (UTI), while in this study, fever, pain, irritability, dysuria and hematuria were the main clinical presentations. It seems that along with nonspecific abdominal pain, UTI may be an important sign of nephrolithiasis. Furthermore, in adolescents, hematuria may need greater evaluation to eliminate other serious problems (52). Moudi et al. (52) (53) (54) also demonstrated that long-term usage of aspirin might induce occult hematuria.
Several reports indicated that most nephrolithiasis in children are calcium based, in which calcium oxalate is the most common type of calculi with about 50% followed by calcium phosphate (10% -20%). Mixed calcium oxalate and calcium phosphate are present in more than 10% and magnesium ammonium phosphate (infection related) stone is reported in more than 17% of patients (33, 36, 37) .
Evaluation 6.4.1. History and Physical Examination
Obtaining an appropriate medical history and physical examination is a milestone for an accurate diagnosis and identification of those who are at risk and need treatment. In this regard, family history of urinary tract diseases may give a clue for metabolic and inherited conditions. The presence of a family history was reported in 23% -75% of patients. In addition, focusing on diet by emphasizing on salt and fluid intake and having a special diet are important. Ketogenic diet increases the risk of uric acid stones. Furthermore, some medications, particularly corticosteroids, diuretics protease inhibitors, vitamins C and D or supplements are associated with nephrolithiasis; hence, there is a need to clarify their usage. Patients with history of prematurity, IBD, CF, anatomical abnormalities or UTI are prone to nephrocalcinosis. Physical exam may be helpful to identify the dysmorphic shape of the body, rickets or other abnormalities of systemic diseases and genetics associated with nephrolithiasis (Table 2 ) (23).
Urinalysis
Urinalysis is the main part of initial assessment of nephrolithiasis. It provides good information of urine gravity as a marker of urine concentration and fluid intake, urine pH, hematuria and pyuria. Microscopic analysis may give good information regarding crystalluria that help clarify the origin of the problem. Tubular dysfunction is presented by glucosuria and proteinuria.
Other Laboratory Evaluations
To evaluate renal function, assessment of electrolyte levels including potassium, sodium, magnesium, calcium and phosphorus are highly recommended. In case of hypercalcemia, hyperparathyroidism may be considered. Hypervitaminose D can lead to hypercalciuria.
The second step is to determine the underlying diseases such as metabolic disorder. It has been demonstrated that in children, metabolic risk factors affect the majority of cases therefore a complete workup in this setting is required. On the other hand, the risk of recurrence is high and in line with metabolic abnormalities. Hence, stone analysis takes an important place and could canalize the physician to identify the risk factors of nephrolithiasis. In fact, in children due to rare spontaneous passage or surgical stone retrieval, stone analysis is not common. Furthermore, Aliramaji et al. (53) in a meta-analysis revealed that urine biomarkers may helpful in diagnosis of ureteropelvic junction obstruction, as a predicting factor. As an alternative, a 24-hour urine collection is a recommended workup. This test permits the screening of elements contributing to the stone-formation process. Due to variability of daily diet and fluid intake regimen, it is required to collect a 24-hour urine sample for evaluating creatinine, sodium, calcium, phosphorus, magnesium, oxalate, citrate, cysteine, uric acid and urine volume. Some authors recommend two 24-hour urine collections. Nevertheless, recent studies indicated the low volume of using this test. In case that the collection is not possible, the urine spot urine samples may be helpful but cannot replace 24-hour urine collection (33, (53) (54) (55) (56) . Normal urinary values in spot urine samples and 24-hour samples are shown in Tables 3  and 4 .
Imaging
Imaging studies during or after the initial laboratory evaluation were required in pediatric nephrolithiasis. In adults, because of high sensitivity and specificity of computerized tomography (CT) scanning and regarding a good image of anatomy, taking a CT without contrast is usually recommended. In children, radiation of CT has been concerned in many recommendations, therefore ultrasonography is recommended by many pediatric associations as an initial imaging evaluation. Ultrasonography with low radiation and low cost simply identifies an echogenic mass and hydronephrosis as a consequence of stone in the kidney. Studies on adults demonstrated that there is no significant difference between CT and US as initial imaging evaluation. However, a pediatric study indicated that sensitivity and specificity of US compared with CT was 76% and 100%, respectively (33, 36, 57).
Management
Acute Management
The initial steps in therapeutic approach in nephrolithiasis are control of acute renal colic pain, recognition of the necessity of emergency intervention, and trying to pass the stone if possible. The second step is to prevent new stone formation.
The pain is usually controlled by analgesics such as non-steroidal anti-inflammatory drug (NSAID) or opium. Children may need hospitalization in case of initiation of parenteral analgesic or hydration. Usually, renal stone in children is not obstructing and emergency decompression is not indicated. However, the size and location of stone must be considered seriously as a stone less than 4 mm has a chance to pass spontaneously in all patients. In children, renal stones pass spontaneously in 50% of cases (36, 58) . In this situation, conservative management may be enough. Besides, medical expulsive therapy such as alphablocker (tamsulosin, terazosin) or calcium channel blockers (nifedipine) may facilitate the passage of small stones by relaxing ureteral smooth muscle. Actually, tamsulosin is wildly prescribed for pediatric nephrolithiasis (59) (60) (61) (62) . The stone passage may take more than one month and in this period, the patients need appropriate care and followup.
Surgical Management
In case of obstructing or large stones, acute intervention and decompression may be required. In this context, urethral stent, nephrostomy, Shock Wave Lithotripsy (SWL) or even removal of stone via ureteroscopy is advised. Previous studies demonstrated that in children, the stone with a size more than 5 mm rarely passes spontaneously. Different studies revealed that about 22% of patients would need surgical therapeutic approach during the next six months after initiation of disease (36, 61, 63) . The choice of each procedure depends on patient's characteristic. While SWL and ureteroscopy are considered for small stones, percutaneous nephrolithotomy and pyelolithotomy are reserved for large calculi (> 1.5 cm) (36, 63) . Generally, by the improvement of endourological techniques, interventions have shifted to minimally invasive procedures. In this setting, ureteroscopy is used commonly and is becoming the therapeutic approach of choice in lower and also upper tract stones (64) (65) (66) . Tejwani et al. (67) in a large study to compare SWL and ureteroscopy demonstrated that patients, who benefit from ureteroscopy, had less stone-related procedures in the next 12 months after the procedure, but a higher rate of readmissions within subsequent month after the initial intervention. Comparison of treatment modalities for surgical management of pediatric nephrolithiasis is summarized in Table 5 (36).
Prevention of Recurrence
Prevention of nephrolithiasis recurrence in children is an effort to determine the potential risk factors of stone formation and their modification. Previous reports indicated that children with known underling metabolic disorder have a 50% risk of recurrence of nephrolithiasis, compared to 10% in patients without these risk factors (58, 66, 68) . Appropriate fluid intake, about 1.5 l/ m 2 /d, and limited dietary intake should be advised to help decrease supersaturation of urinary elements such as calcium, oxalate and uric acid. The fluid intake could be enough to provide urine volume more than 750 mL/d in infants and more than 1000 mL/d for children less than five years old, 1500 mL/d for children 5 to 10 years, and 2000 mL/d in children more than 10 years. Children need appropriate dietary calcium and calcium restriction is not recommended. Excessive protein intake can lead to hypercalciuria and hypocitraturia; hence a sufficient protein intake is recommended (20, 30, 31, 36) . Furthermore, avoidance of medication that may cause nephrolithiasis should be considered. Medication may be a part of management of children with recurrent nephrolithiasis, solitary kidney, or metabolic disorders. In this context, the result of stone analysis or a 24-hour urine collection analysis plays an important role (33, 39, 69, 70) . Thiazides and potassium-sparing diuretics are on top of the list. In a case with hypocitraturia, potassium and citrate can increase the urinary Ph and prevent uric acid crystallization. Patients with hypercalciuria benefit from thiazide diuretics, which decreases urinary calcium excretion. In this condition, a low sodium diet and adequate fluid intake must be encouraged. However, in presence of hypercalcemia, the prescription of thiazide is forbidden and combination of thiazide and potassiumsparing diuretics can increase calcium absorption (36, 66) . The treatment of hyperoxaluria includes prevention of oxalate absorption by reducing the intake of oxalate -rich foods and preventing crystallization of calcium oxalate in the urine. Usually, pyridoxine can be empirically prescribed. In fact, hyperoxaluria, secondary to malabsorption syndromes, requires treatment of underlying disease (15, 31, 33) . Moreover, magnesium and pyrophosphate may prevent calcium oxalate crystallization. In case of citric acid stones, the increase of excretion of citric acid by urinary alkalization is a helpful modality. Allopurinol can be used in patients with purine metabolism disorders. Furthermore, alkalization can be used for the treatment of cyctine stone. The aim is to reach a urinary pH of 7 -7.5. Potassium citrate is recommended. Similarly, D-penicillamine and Tiopronin (Alpha-mercaptopropionylglycine) can be used in cystinuria. However, generally speaking, conservative management remains the first line of management of patients with nephrolithiasis.
Conclusions
Pediatric nephrolithiasis, because of changing trend and underlying risk factors is different in adults. The aim of the treatment is to preserve the function of kidney and prevent the recurrence of disease. Metabolic disorders are important in this setting and work up is recommended. Despite advances in technology and medication, the risk factor modifications remain the basis for the treatment of nephrolithiasis. 
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Abbreviation: HGPRT, hypoxanthine phosphoribosyl transferase. Abbreviation: GFR, glomerular filtration rate. a Calculated by multiplying the ratio of uric acid to creatinine (mg/mg) with serum creatinine (mg/dL) (71). 
